Add to ORKGIL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthriti
The pathogenesis of joint destruction in rheumatoid arthritis remains ill-defined. Joint destruction...
International audienceInterleukin-6 (IL-6) is a key cytokine in rheumatoid arthritis pathogenesis. W...
How pathogenic cluster of differentiation 4 (CD4) T cells in rheumatoid arthritis (RA) develop remai...
Objectives A previously identified signal transduction and activator of transcription-3 (STAT3) targ...
To find novel predictors of treatment response to disease-modifying antirheumatic drugs (DMARDs), we...
Rheumatoid arthritis is a chronic autoimmune disease occurring in ~1% of the world population. The m...
Rheumatoid arthritis (RA) is a systemic and incurable autoimmune disease characterized by chronic in...
International audienceOBJECTIVE: To identify a specific pattern of serum cytokines that correlates w...
Therapeutic blockage of cytokine signalling in autoimmune diseases has improved our understanding of...
IL-6–mediated T cell-driven immune responses are associated with signaling occurring through the mem...
AbstractRheumatoid arthritis (RA), one of the most common autoimmune disorders, is believed to be me...
Objective. The role of natural killer (NK) cells in the immunopathogenesis of rheumatoid arthritis (...
Abstract Background Follicular helper T (Tfh) cells are specialized in helping B lymphocytes, which ...
Objective To determine whether interleukin-6 (IL-6) trans-signaling directs the expression of pre-...
The pathogenesis of joint destruction in rheumatoid arthritis remains ill-defined. Joint destruction...
International audienceInterleukin-6 (IL-6) is a key cytokine in rheumatoid arthritis pathogenesis. W...
How pathogenic cluster of differentiation 4 (CD4) T cells in rheumatoid arthritis (RA) develop remai...
Objectives A previously identified signal transduction and activator of transcription-3 (STAT3) targ...
To find novel predictors of treatment response to disease-modifying antirheumatic drugs (DMARDs), we...
Rheumatoid arthritis is a chronic autoimmune disease occurring in ~1% of the world population. The m...
Rheumatoid arthritis (RA) is a systemic and incurable autoimmune disease characterized by chronic in...
International audienceOBJECTIVE: To identify a specific pattern of serum cytokines that correlates w...
Therapeutic blockage of cytokine signalling in autoimmune diseases has improved our understanding of...
IL-6–mediated T cell-driven immune responses are associated with signaling occurring through the mem...
AbstractRheumatoid arthritis (RA), one of the most common autoimmune disorders, is believed to be me...
Objective. The role of natural killer (NK) cells in the immunopathogenesis of rheumatoid arthritis (...
Abstract Background Follicular helper T (Tfh) cells are specialized in helping B lymphocytes, which ...
Objective To determine whether interleukin-6 (IL-6) trans-signaling directs the expression of pre-...
The pathogenesis of joint destruction in rheumatoid arthritis remains ill-defined. Joint destruction...
International audienceInterleukin-6 (IL-6) is a key cytokine in rheumatoid arthritis pathogenesis. W...
How pathogenic cluster of differentiation 4 (CD4) T cells in rheumatoid arthritis (RA) develop remai...